APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Ophthalmic Steroids Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Ophthalmic Steroids Drug Industry Growth and Trends Forecast to 2032

Report ID 174019180131 December 2025109 pages

Choose your research edition.

Industry ResearchOphthalmic Steroids Drug Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Ophthalmic Steroids Drug Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Ophthalmic Steroids Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ophthalmic Steroids Drug Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Ophthalmic Steroids Drug Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Ophthalmic Steroids Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Ophthalmic Steroids Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Ophthalmic Steroids Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ophthalmic Steroids Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ophthalmic Steroids Drug include Alimera Sciences, Allergan, Bausch and Lomb, Genentech, Novartis AG, Regeneron Pharmaceuticals, Valeant Pharmaceuticals International, Bayer AG and GlaxoSmithKline, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Ophthalmic Steroids Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Ophthalmic Steroids Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ophthalmic Steroids Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ophthalmic Steroids Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Ophthalmic Steroids Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Ophthalmic Steroids Drug Market by Company

Alimera Sciences

Allergan

Bausch and Lomb

Genentech

Novartis AG

Regeneron Pharmaceuticals

Valeant Pharmaceuticals International

Bayer AG

GlaxoSmithKline

Pfizer

Ophthalmic Steroids Drug Segment by Type

Allergic Conjunctivitis

Keratitis

Uveitis

Diabetic Macular Edema

Others

Ophthalmic Steroids Drug Segment by Application

Retail Pharmacies

Online Pharmacies

Research Institute

Hospital Pharmacies

Others

Ophthalmic Steroids Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ophthalmic Steroids Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ophthalmic Steroids Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ophthalmic Steroids Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ophthalmic Steroids Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Ophthalmic Steroids Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Allergic Conjunctivitis Table 2. Major Company of Keratitis Table 3. Major Company of Uveitis Table 4. Major Company of Diabetic Macular Edema Table 5. Major Company of Others Table 6. Global Ophthalmic Steroids Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Ophthalmic Steroids Drug Sales by Type (2021-2026) & (K Units) Table 8. Global Ophthalmic Steroids Drug Sales Market Share in Volume by Type (2021-2026) Table 9. Global Ophthalmic Steroids Drug Sales by Type (2021-2026) & (US$ Million) Table 10. Global Ophthalmic Steroids Drug Sales Market Share in Value by Type (2021-2026) Table 11. Global Ophthalmic Steroids Drug Price by Type (2021-2026) & (US$/Unit) Table 12. Global Ophthalmic Steroids Drug Sales by Type (2027-2032) & (K Units) Table 13. Global Ophthalmic Steroids Drug Sales Market Share in Volume by Type (2027-2032) Table 14. Global Ophthalmic Steroids Drug Sales by Type (2027-2032) & (US$ Million) Table 15. Global Ophthalmic Steroids Drug Sales Market Share in Value by Type (2027-2032) Table 16. Global Ophthalmic Steroids Drug Price by Type (2027-2032) & (US$/Unit) Table 17. North America Ophthalmic Steroids Drug Sales by Type (2021-2026) & (K Units) Table 18. North America Ophthalmic Steroids Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Ophthalmic Steroids Drug Sales by Type (2021-2026) & (K Units) Table 20. Europe Ophthalmic Steroids Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Ophthalmic Steroids Drug Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Ophthalmic Steroids Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Ophthalmic Steroids Drug Sales by Type (2021-2026) & (K Units) Table 24. Latin America Ophthalmic Steroids Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Ophthalmic Steroids Drug Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Ophthalmic Steroids Drug Sales by Type (2021-2026) & (US$ Million) Table 27. Ophthalmic Steroids Drug Industry Trends Table 28. Ophthalmic Steroids Drug Industry Drivers Table 29. Ophthalmic Steroids Drug Industry Opportunities and Challenges Table 30. Ophthalmic Steroids Drug Industry Restraints Table 31. Global Ophthalmic Steroids Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Ophthalmic Steroids Drug Revenue Market Share by Company (2021-2026) Table 33. Global Ophthalmic Steroids Drug Sales by Company (2021-2026) & (K Units) Table 34. Global Ophthalmic Steroids Drug Sales Share by Company (2021-2026) Table 35. Global Ophthalmic Steroids Drug Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Ophthalmic Steroids Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Ophthalmic Steroids Drug Major Company Production Sites and Headquarters Table 38. Global Ophthalmic Steroids Drug Company, Product Type & Application Table 39. Global Ophthalmic Steroids Drug Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Ophthalmic Steroids Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Ophthalmic Steroids Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Ophthalmic Steroids Drug Sales by Region (2021-2026) & (K Units) Table 44. Global Ophthalmic Steroids Drug Sales Market Share in Volume by Region (2021-2026) Table 45. Global Ophthalmic Steroids Drug Sales by Region (2021-2026) & (US$ Million) Table 46. Global Ophthalmic Steroids Drug Sales Market Share in Value by Region (2021-2026) Table 47. Global Ophthalmic Steroids Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Ophthalmic Steroids Drug Sales by Region (2027-2032) & (K Units) Table 49. Global Ophthalmic Steroids Drug Sales Market Share in Volume by Region (2027-2032) Table 50. Global Ophthalmic Steroids Drug Sales by Region (2027-2032) & (US$ Million) Table 51. Global Ophthalmic Steroids Drug Sales Market Share in Value by Region (2027-2032) Table 52. Global Ophthalmic Steroids Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Ophthalmic Steroids Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Ophthalmic Steroids Drug Sales by Application (2021-2026) & (K Units) Table 55. Global Ophthalmic Steroids Drug Sales Market Share in Volume by Application (2021-2026) Table 56. Global Ophthalmic Steroids Drug Sales by Application (2021-2026) & (US$ Million) Table 57. Global Ophthalmic Steroids Drug Sales Market Share in Value by Application (2021-2026) Table 58. Global Ophthalmic Steroids Drug Price by Application (2021-2026) & (US$/Unit) Table 59. Global Ophthalmic Steroids Drug Sales by Application (2027-2032) & (K Units) Table 60. Global Ophthalmic Steroids Drug Sales Market Share in Volume by Application (2027-2032) Table 61. Global Ophthalmic Steroids Drug Sales by Application (2027-2032) & (US$ Million) Table 62. Global Ophthalmic Steroids Drug Sales Market Share in Value by Application (2027-2032) Table 63. Global Ophthalmic Steroids Drug Price by Application (2027-2032) & (US$/Unit) Table 64. North America Ophthalmic Steroids Drug Sales by Application (2021-2026) & (K Units) Table 65. North America Ophthalmic Steroids Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Ophthalmic Steroids Drug Sales by Application (2021-2026) & (K Units) Table 67. Europe Ophthalmic Steroids Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Ophthalmic Steroids Drug Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Ophthalmic Steroids Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Ophthalmic Steroids Drug Sales by Application (2021-2026) & (K Units) Table 71. Latin America Ophthalmic Steroids Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Ophthalmic Steroids Drug Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Ophthalmic Steroids Drug Sales by Application (2021-2026) & (US$ Million) Table 74. Alimera Sciences Company Information Table 75. Alimera Sciences Business Overview Table 76. Alimera Sciences Ophthalmic Steroids Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Alimera Sciences Ophthalmic Steroids Drug Product Portfolio Table 78. Alimera Sciences Recent Development Table 79. Allergan Company Information Table 80. Allergan Business Overview Table 81. Allergan Ophthalmic Steroids Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Allergan Ophthalmic Steroids Drug Product Portfolio Table 83. Allergan Recent Development Table 84. Bausch and Lomb Company Information Table 85. Bausch and Lomb Business Overview Table 86. Bausch and Lomb Ophthalmic Steroids Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Bausch and Lomb Ophthalmic Steroids Drug Product Portfolio Table 88. Bausch and Lomb Recent Development Table 89. Genentech Company Information Table 90. Genentech Business Overview Table 91. Genentech Ophthalmic Steroids Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Genentech Ophthalmic Steroids Drug Product Portfolio Table 93. Genentech Recent Development Table 94. Novartis AG Company Information Table 95. Novartis AG Business Overview Table 96. Novartis AG Ophthalmic Steroids Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Novartis AG Ophthalmic Steroids Drug Product Portfolio Table 98. Novartis AG Recent Development Table 99. Regeneron Pharmaceuticals Company Information Table 100. Regeneron Pharmaceuticals Business Overview Table 101. Regeneron Pharmaceuticals Ophthalmic Steroids Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Regeneron Pharmaceuticals Ophthalmic Steroids Drug Product Portfolio Table 103. Regeneron Pharmaceuticals Recent Development Table 104. Valeant Pharmaceuticals International Company Information Table 105. Valeant Pharmaceuticals International Business Overview Table 106. Valeant Pharmaceuticals International Ophthalmic Steroids Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Valeant Pharmaceuticals International Ophthalmic Steroids Drug Product Portfolio Table 108. Valeant Pharmaceuticals International Recent Development Table 109. Bayer AG Company Information Table 110. Bayer AG Business Overview Table 111. Bayer AG Ophthalmic Steroids Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Bayer AG Ophthalmic Steroids Drug Product Portfolio Table 113. Bayer AG Recent Development Table 114. GlaxoSmithKline Company Information Table 115. GlaxoSmithKline Business Overview Table 116. GlaxoSmithKline Ophthalmic Steroids Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. GlaxoSmithKline Ophthalmic Steroids Drug Product Portfolio Table 118. GlaxoSmithKline Recent Development Table 119. Pfizer Company Information Table 120. Pfizer Business Overview Table 121. Pfizer Ophthalmic Steroids Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Pfizer Ophthalmic Steroids Drug Product Portfolio Table 123. Pfizer Recent Development Table 124. North America Ophthalmic Steroids Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 125. North America Ophthalmic Steroids Drug Sales by Country (2021-2026) & (K Units) Table 126. North America Ophthalmic Steroids Drug Sales Market Share by Country (2021-2026) Table 127. North America Ophthalmic Steroids Drug Sales Forecast by Country (2027-2032) & (K Units) Table 128. North America Ophthalmic Steroids Drug Sales Market Share Forecast by Country (2027-2032) Table 129. North America Ophthalmic Steroids Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. North America Ophthalmic Steroids Drug Market Size by Country (2021-2026) & (US$ Million) Table 131. North America Ophthalmic Steroids Drug Market Share by Country (2021-2026) Table 132. North America Ophthalmic Steroids Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. North America Ophthalmic Steroids Drug Market Share Forecast by Country (2027-2032) Table 134. Europe Ophthalmic Steroids Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 135. Europe Ophthalmic Steroids Drug Sales by Country (2021-2026) & (K Units) Table 136. Europe Ophthalmic Steroids Drug Sales Market Share by Country (2021-2026) Table 137. Europe Ophthalmic Steroids Drug Sales Forecast by Country (2027-2032) & (K Units) Table 138. Europe Ophthalmic Steroids Drug Sales Market Share Forecast by Country (2027-2032) Table 139. Europe Ophthalmic Steroids Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Europe Ophthalmic Steroids Drug Market Size by Country (2021-2026) & (US$ Million) Table 141. Europe Ophthalmic Steroids Drug Market Share by Country (2021-2026) Table 142. Europe Ophthalmic Steroids Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Europe Ophthalmic Steroids Drug Market Share Forecast by Country (2027-2032) Table 144. Asia-Pacific Ophthalmic Steroids Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 145. Asia-Pacific Ophthalmic Steroids Drug Sales by Country (2021-2026) & (K Units) Table 146. Asia-Pacific Ophthalmic Steroids Drug Sales Market Share by Country (2021-2026) Table 147. Asia-Pacific Ophthalmic Steroids Drug Sales Forecast by Country (2027-2032) & (K Units) Table 148. Asia-Pacific Ophthalmic Steroids Drug Sales Market Share Forecast by Country (2027-2032) Table 149. Asia-Pacific Ophthalmic Steroids Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Asia-Pacific Ophthalmic Steroids Drug Market Size by Country (2021-2026) & (US$ Million) Table 151. Asia-Pacific Ophthalmic Steroids Drug Market Share by Country (2021-2026) Table 152. Asia-Pacific Ophthalmic Steroids Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Asia-Pacific Ophthalmic Steroids Drug Market Share Forecast by Country (2027-2032) Table 154. Latin America Ophthalmic Steroids Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 155. Latin America Ophthalmic Steroids Drug Sales by Country (2021-2026) & (K Units) Table 156. Latin America Ophthalmic Steroids Drug Sales Market Share by Country (2021-2026) Table 157. Latin America Ophthalmic Steroids Drug Sales Forecast by Country (2027-2032) & (K Units) Table 158. Latin America Ophthalmic Steroids Drug Sales Market Share Forecast by Country (2027-2032) Table 159. Latin America Ophthalmic Steroids Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Latin America Ophthalmic Steroids Drug Market Size by Country (2021-2026) & (US$ Million) Table 161. Latin America Ophthalmic Steroids Drug Market Share by Country (2021-2026) Table 162. Latin America Ophthalmic Steroids Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Latin America Ophthalmic Steroids Drug Market Share Forecast by Country (2027-2032) Table 164. Middle East and Africa Ophthalmic Steroids Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 165. Middle East and Africa Ophthalmic Steroids Drug Sales by Country (2021-2026) & (K Units) Table 166. Middle East and Africa Ophthalmic Steroids Drug Sales Market Share by Country (2021-2026) Table 167. Middle East and Africa Ophthalmic Steroids Drug Sales Forecast by Country (2027-2032) & (K Units) Table 168. Middle East and Africa Ophthalmic Steroids Drug Sales Market Share Forecast by Country (2027-2032) Table 169. Middle East and Africa Ophthalmic Steroids Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 170. Middle East and Africa Ophthalmic Steroids Drug Market Size by Country (2021-2026) & (US$ Million) Table 171. Middle East and Africa Ophthalmic Steroids Drug Market Share by Country (2021-2026) Table 172. Middle East and Africa Ophthalmic Steroids Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 173. Middle East and Africa Ophthalmic Steroids Drug Market Share Forecast by Country (2027-2032) Table 174. Key Raw Materials Table 175. Raw Materials Key Suppliers Table 176. Ophthalmic Steroids Drug Distributors List Table 177. Ophthalmic Steroids Drug Customers List Table 178. Research Programs/Design for This Report Table 179. Authors List of This Report Table 180. Secondary Sources Table 181. Primary Sources List of Figures Figure 1. Ophthalmic Steroids Drug Image Figure 2. Global Ophthalmic Steroids Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ophthalmic Steroids Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Ophthalmic Steroids Drug Sales (2021-2032) & (K Units) Figure 5. Allergic Conjunctivitis Image Figure 6. Global Allergic Conjunctivitis Sales YoY Growth (2021-2032) & (K Units) Figure 7. Keratitis Image Figure 8. Global Keratitis Sales YoY Growth (2021-2032) & (K Units) Figure 9. Uveitis Image Figure 10. Global Uveitis Sales YoY Growth (2021-2032) & (K Units) Figure 11. Diabetic Macular Edema Image Figure 12. Global Diabetic Macular Edema Sales YoY Growth (2021-2032) & (K Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Ophthalmic Steroids Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Ophthalmic Steroids Drug Market Share by Type 2025 VS 2032 Figure 17. North America Ophthalmic Steroids Drug Sales Market Share in Volume by Type in 2025 Figure 18. North America Ophthalmic Steroids Drug Sales Market Share in Value by Type in 2025 Figure 19. Europe Ophthalmic Steroids Drug Sales Market Share in Volume by Type in 2025 Figure 20. Europe Ophthalmic Steroids Drug Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Ophthalmic Steroids Drug Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Ophthalmic Steroids Drug Sales Market Share in Value by Type in 2025 Figure 23. Latin America Ophthalmic Steroids Drug Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Ophthalmic Steroids Drug Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Ophthalmic Steroids Drug Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Ophthalmic Steroids Drug Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Ophthalmic Steroids Drug Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Retail Pharmacies Image Figure 30. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 31. Online Pharmacies Image Figure 32. Global Online Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 33. Research Institute Image Figure 34. Global Research Institute Sales YoY Growth (2021-2032) & (K Units) Figure 35. Hospital Pharmacies Image Figure 36. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 39. Global Ophthalmic Steroids Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Ophthalmic Steroids Drug Market Share by Application 2025 VS 2032 Figure 41. North America Ophthalmic Steroids Drug Sales Market Share in Volume by Application in 2025 Figure 42. North America Ophthalmic Steroids Drug Sales Market Share in Value by Application in 2025 Figure 43. Europe Ophthalmic Steroids Drug Sales Market Share in Volume by Application in 2025 Figure 44. Europe Ophthalmic Steroids Drug Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Ophthalmic Steroids Drug Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Ophthalmic Steroids Drug Sales Market Share in Value by Application in 2025 Figure 47. Latin America Ophthalmic Steroids Drug Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Ophthalmic Steroids Drug Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Ophthalmic Steroids Drug Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Ophthalmic Steroids Drug Sales Market Share in Value by Application in 2025 Figure 51. North America Ophthalmic Steroids Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. North America Ophthalmic Steroids Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Ophthalmic Steroids Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Ophthalmic Steroids Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Ophthalmic Steroids Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Europe Ophthalmic Steroids Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Ophthalmic Steroids Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Ophthalmic Steroids Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Ophthalmic Steroids Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Asia-Pacific Ophthalmic Steroids Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Ophthalmic Steroids Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Ophthalmic Steroids Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Ophthalmic Steroids Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Latin America Ophthalmic Steroids Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Ophthalmic Steroids Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Ophthalmic Steroids Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Ophthalmic Steroids Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 68. Middle East and Africa Ophthalmic Steroids Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Ophthalmic Steroids Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Ophthalmic Steroids Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Ophthalmic Steroids Drug Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Ophthalmic Steroids Drug Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Allergic Conjunctivitis
  • Keratitis
  • Uveitis
  • Diabetic Macular Edema
  • Others
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Research Institute
  • Hospital Pharmacies
  • Others
Companies covered
  • Alimera Sciences
  • Allergan
  • Bausch and Lomb
  • Genentech
  • Novartis AG
  • Regeneron Pharmaceuticals
  • Valeant Pharmaceuticals International
  • Bayer AG
  • GlaxoSmithKline
  • Pfizer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ophthalmic Steroids Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Ophthalmic Steroids Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Ophthalmic Steroids Drug Market by Type
  6. 1.3.1 Allergic Conjunctivitis
  7. 1.3.2 Keratitis
  8. 1.3.3 Uveitis
  9. 1.3.4 Diabetic Macular Edema
  10. 1.3.5 Others
  11. 1.4 Global Ophthalmic Steroids Drug Market Size by Type
  12. 1.4.1 Global Ophthalmic Steroids Drug Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Ophthalmic Steroids Drug Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Ophthalmic Steroids Drug Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Ophthalmic Steroids Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Ophthalmic Steroids Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Ophthalmic Steroids Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Ophthalmic Steroids Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Ophthalmic Steroids Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Ophthalmic Steroids Drug Industry Trends
  2. 2.2 Ophthalmic Steroids Drug Industry Drivers
  3. 2.3 Ophthalmic Steroids Drug Industry Opportunities and Challenges
  4. 2.4 Ophthalmic Steroids Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Ophthalmic Steroids Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Ophthalmic Steroids Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Ophthalmic Steroids Drug Price (2021-2026)
  4. 3.4 Global Ophthalmic Steroids Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ophthalmic Steroids Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Ophthalmic Steroids Drug Company, Product Type & Application
  7. 3.7 Global Ophthalmic Steroids Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ophthalmic Steroids Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ophthalmic Steroids Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ophthalmic Steroids Drug Tier 1, Tier 2, and Tier 3
4 Ophthalmic Steroids Drug Regional Status and Outlook
  1. 4.1 Global Ophthalmic Steroids Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Ophthalmic Steroids Drug Historic Market Size by Region
  3. 4.2.1 Global Ophthalmic Steroids Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Ophthalmic Steroids Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Ophthalmic Steroids Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Ophthalmic Steroids Drug Forecasted Market Size by Region
  7. 4.3.1 Global Ophthalmic Steroids Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Ophthalmic Steroids Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Ophthalmic Steroids Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Ophthalmic Steroids Drug by Application
  1. 5.1 Ophthalmic Steroids Drug Market by Application
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Research Institute
  5. 5.1.4 Hospital Pharmacies
  6. 5.1.5 Others
  7. 5.2 Global Ophthalmic Steroids Drug Market Size by Application
  8. 5.2.1 Global Ophthalmic Steroids Drug Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Ophthalmic Steroids Drug Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Ophthalmic Steroids Drug Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Ophthalmic Steroids Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Ophthalmic Steroids Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Ophthalmic Steroids Drug Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Ophthalmic Steroids Drug Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Ophthalmic Steroids Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Alimera Sciences
  2. 6.1.1 Alimera Sciences Company Information
  3. 6.1.2 Alimera Sciences Business Overview
  4. 6.1.3 Alimera Sciences Ophthalmic Steroids Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Alimera Sciences Ophthalmic Steroids Drug Product Portfolio
  6. 6.1.5 Alimera Sciences Recent Developments
  7. 6.2 Allergan
  8. 6.2.1 Allergan Company Information
  9. 6.2.2 Allergan Business Overview
  10. 6.2.3 Allergan Ophthalmic Steroids Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Allergan Ophthalmic Steroids Drug Product Portfolio
  12. 6.2.5 Allergan Recent Developments
  13. 6.3 Bausch and Lomb
  14. 6.3.1 Bausch and Lomb Company Information
  15. 6.3.2 Bausch and Lomb Business Overview
  16. 6.3.3 Bausch and Lomb Ophthalmic Steroids Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Bausch and Lomb Ophthalmic Steroids Drug Product Portfolio
  18. 6.3.5 Bausch and Lomb Recent Developments
  19. 6.4 Genentech
  20. 6.4.1 Genentech Company Information
  21. 6.4.2 Genentech Business Overview
  22. 6.4.3 Genentech Ophthalmic Steroids Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Genentech Ophthalmic Steroids Drug Product Portfolio
  24. 6.4.5 Genentech Recent Developments
  25. 6.5 Novartis AG
  26. 6.5.1 Novartis AG Company Information
  27. 6.5.2 Novartis AG Business Overview
  28. 6.5.3 Novartis AG Ophthalmic Steroids Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Novartis AG Ophthalmic Steroids Drug Product Portfolio
  30. 6.5.5 Novartis AG Recent Developments
  31. 6.6 Regeneron Pharmaceuticals
  32. 6.6.1 Regeneron Pharmaceuticals Company Information
  33. 6.6.2 Regeneron Pharmaceuticals Business Overview
  34. 6.6.3 Regeneron Pharmaceuticals Ophthalmic Steroids Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Regeneron Pharmaceuticals Ophthalmic Steroids Drug Product Portfolio
  36. 6.6.5 Regeneron Pharmaceuticals Recent Developments
  37. 6.7 Valeant Pharmaceuticals International
  38. 6.7.1 Valeant Pharmaceuticals International Company Information
  39. 6.7.2 Valeant Pharmaceuticals International Business Overview
  40. 6.7.3 Valeant Pharmaceuticals International Ophthalmic Steroids Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Valeant Pharmaceuticals International Ophthalmic Steroids Drug Product Portfolio
  42. 6.7.5 Valeant Pharmaceuticals International Recent Developments
  43. 6.8 Bayer AG
  44. 6.8.1 Bayer AG Company Information
  45. 6.8.2 Bayer AG Business Overview
  46. 6.8.3 Bayer AG Ophthalmic Steroids Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Bayer AG Ophthalmic Steroids Drug Product Portfolio
  48. 6.8.5 Bayer AG Recent Developments
  49. 6.9 GlaxoSmithKline
  50. 6.9.1 GlaxoSmithKline Company Information
  51. 6.9.2 GlaxoSmithKline Business Overview
  52. 6.9.3 GlaxoSmithKline Ophthalmic Steroids Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 GlaxoSmithKline Ophthalmic Steroids Drug Product Portfolio
  54. 6.9.5 GlaxoSmithKline Recent Developments
  55. 6.10 Pfizer
  56. 6.10.1 Pfizer Company Information
  57. 6.10.2 Pfizer Business Overview
  58. 6.10.3 Pfizer Ophthalmic Steroids Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Pfizer Ophthalmic Steroids Drug Product Portfolio
  60. 6.10.5 Pfizer Recent Developments
7 North America by Country
  1. 7.1 North America Ophthalmic Steroids Drug Sales by Country
  2. 7.1.1 North America Ophthalmic Steroids Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Ophthalmic Steroids Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Ophthalmic Steroids Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Ophthalmic Steroids Drug Market Size by Country
  6. 7.2.1 North America Ophthalmic Steroids Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Ophthalmic Steroids Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Ophthalmic Steroids Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Ophthalmic Steroids Drug Sales by Country
  2. 8.1.1 Europe Ophthalmic Steroids Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Ophthalmic Steroids Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Ophthalmic Steroids Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Ophthalmic Steroids Drug Market Size by Country
  6. 8.2.1 Europe Ophthalmic Steroids Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Ophthalmic Steroids Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Ophthalmic Steroids Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Ophthalmic Steroids Drug Sales by Country
  2. 9.1.1 Asia-Pacific Ophthalmic Steroids Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Ophthalmic Steroids Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Ophthalmic Steroids Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Ophthalmic Steroids Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Ophthalmic Steroids Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Ophthalmic Steroids Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Ophthalmic Steroids Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Ophthalmic Steroids Drug Sales by Country
  2. 10.1.1 South America Ophthalmic Steroids Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Ophthalmic Steroids Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Ophthalmic Steroids Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Ophthalmic Steroids Drug Market Size by Country
  6. 10.2.1 South America Ophthalmic Steroids Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Ophthalmic Steroids Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Ophthalmic Steroids Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Ophthalmic Steroids Drug Sales by Country
  2. 11.1.1 Middle East and Africa Ophthalmic Steroids Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Ophthalmic Steroids Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Ophthalmic Steroids Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Ophthalmic Steroids Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Ophthalmic Steroids Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Ophthalmic Steroids Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Ophthalmic Steroids Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Ophthalmic Steroids Drug Value Chain Analysis
  2. 12.1.1 Ophthalmic Steroids Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Ophthalmic Steroids Drug Production Mode & Process
  7. 12.2 Ophthalmic Steroids Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Ophthalmic Steroids Drug Distributors
  10. 12.2.3 Ophthalmic Steroids Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst